Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 1

Interventions

Methotrexate 4Abatacept 3tocilizumab 2olokizumab 2Rituximab 2tofacitinib 1secukinumab 1golimumab 1baricitinib 1Radioimmunodetection 1RC-18 1Etanercept 1Double-Blind Method 1Certolizumab Pegol 1Antirheumatic Agents 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Arthritis, Rheumatoid × Double-Blind Method × Clear all
NCT00960440 2018-12-19

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Pfizer

Phase 3 Completed
399 enrolled 51 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡